We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETQ
14276
PUT
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-14,100
Closed -$344K
VSACU
14277
DELISTED
Vision Sensing Acquisition Corp. Unit
VSACU
-10,097
Closed -$101K
QQQN
14278
DELISTED
VictoryShares Nasdaq Next 50 ETF
QQQN
-20,475
Closed -$593K
BBSA
14279
DELISTED
JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF
BBSA
-6,664
Closed -$326K
ORGS
14280
PUT
DELISTED
Orgenesis Inc. Common Stock
ORGS
-1,050
Closed -$36K
ALPP
14281
DELISTED
Alpine 4 Holdings Inc
ALPP
-11,381
Closed -$73K
CHUY
14282
PUT
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
-8,900
Closed -$240K
RNLX
14283
CALL
DELISTED
Renalytix plc American Depositary Shares
RNLX
-16,500
Closed -$114K
AAN
14284
PUT
DELISTED
The Aaron's Company Inc
AAN
-10,500
Closed -$211K
LCW
14285
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
-700,131
Closed -$6.9M
EGRX
14286
PUT
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-9,800
Closed -$485K
DXYN
14287
CALL
DELISTED
Dixie Group Inc
DXYN
-15,700
Closed -$49K
DXYN
14288
PUT
DELISTED
Dixie Group Inc
DXYN
-10,900
Closed -$34K
PRFT
14289
DELISTED
Perficient Inc
PRFT
-2,345
Closed -$233K
XFINW
14290
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
-300,200
Closed -$102K
PWSC
14291
PUT
DELISTED
PowerSchool Holdings, Inc.
PWSC
-11,900
Closed -$196K
XFIN
14292
DELISTED
ExcelFin Acquisition Corp Class A Common Stock
XFIN
-700,060
Closed -$6.98M
CALT
14293
CALL
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
-10,300
Closed -$191K
GTHX
14294
CALL
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-26,000
Closed -$198K
SILK
14295
CALL
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
-23,400
Closed -$966K
VLD
14296
PUT
DELISTED
Velo3D, Inc.
VLD
-666
Closed -$217K
CNDA
14297
DELISTED
Concord Acquisition Corp II
CNDA
-2,245,960
Closed -$21.7M
LCW.WS
14298
DELISTED
Learn CW Investment Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
LCW.WS
-352,129
Closed -$110K
BIMI
14299
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
-2,269
Closed -$31K
AIU
14300
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
-2,028
Closed -$16K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.